JAK inhibitor selection in challenging scenarios of myelofibrosis: a review.

Vachhani P, Mesa R, Mascarenhas J, Rampal R, Oh ST, Vannucchi AM, Fox ML, Palandri F, Passamonti F, Kiladjian JJ, Azimi M, Harrison C, Bose P

Open source

DOI: 10.3324/haematol.2025.288654
Published: 2026 Apr 1
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2025.288654,
  title = {JAK inhibitor selection in challenging scenarios of myelofibrosis: a review.},
  author = {Vachhani P and Mesa R and Mascarenhas J and Rampal R and Oh ST and Vannucchi AM and Fox ML and Palandri F and Passamonti F and Kiladjian JJ and Azimi M and Harrison C and Bose P},
  year = {2026},
  journal = {Haematologica},
  doi = {10.3324/haematol.2025.288654},
  url = {https://doi.org/10.3324/haematol.2025.288654}
}

RIS

TY  - JOUR
TI  - JAK inhibitor selection in challenging scenarios of myelofibrosis: a review.
AU  - Vachhani P
AU  - Mesa R
AU  - Mascarenhas J
AU  - Rampal R
AU  - Oh ST
AU  - Vannucchi AM
AU  - Fox ML
AU  - Palandri F
AU  - Passamonti F
AU  - Kiladjian JJ
AU  - Azimi M
AU  - Harrison C
AU  - Bose P
PY  - 2026
JO  - Haematologica
DO  - 10.3324/haematol.2025.288654
UR  - https://doi.org/10.3324/haematol.2025.288654
ER  -

APA

P, V., R, M., J, M., R, R., ST, O., AM, V., ML, F., F, P., F, P., JJ, K., M, A., C, H., & P, B. (2026). JAK inhibitor selection in challenging scenarios of myelofibrosis: a review.. Haematologica. https://doi.org/10.3324/haematol.2025.288654

Source records

pubmed · retrieved 2026-09-26T09:45:24.247Z